tradingkey.logo
搜索

Enovis Corp

ENOV
添加自选
29.150USD
-0.140-0.48%
收盘 07-31 16:00美东报价延迟15分钟
1.68B总市值
亏损市盈率 TTM

关于 Enovis Corp 公司

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp简介

公司代码ENOV
公司名称Enovis Corp
上市日期May 08, 2008
CEOMcdonald (Damien)
员工数量7367
证券类型Ordinary Share
年结日May 08
公司地址2711 Centerville Road
城市WILMINGTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编19808
电话13022529160
网址https://www.enovis.com/
公司代码ENOV
上市日期May 08, 2008
CEOMcdonald (Damien)

Enovis Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
19.22K
+4.40%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%
Ms. Barbara W. Bodem
Ms. Barbara W. Bodem
Independent Director
Independent Director
17.60K
+53.09%
Mr. A. Clayton Perfall
Mr. A. Clayton Perfall
Independent Director
Independent Director
--
--
Mr. Brady R. Shirley
Mr. Brady R. Shirley
Director
Director
--
--
Mr. Bradley J. (Brad) Tandy, J.D.
Mr. Bradley J. (Brad) Tandy, J.D.
Senior Vice President, Chief Legal Officer
Senior Vice President, Chief Legal Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Daniel Alexis Pryor
Mr. Daniel Alexis Pryor
Executive Vice President - Strategy and Business Development
Executive Vice President - Strategy and Business Development
127.55K
+10.74%
Ms. Sharon L. Wienbar
Ms. Sharon L. Wienbar
Independent Chairman of the Board
Independent Chairman of the Board
41.95K
+22.28%
Mr. Rajiv Vinnakota
Mr. Rajiv Vinnakota
Independent Director
Independent Director
27.46K
+34.03%
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Independent Director
Independent Director
22.35K
+41.81%
Dr. Christine Ortiz, Ph.D.
Dr. Christine Ortiz, Ph.D.
Independent Director
Independent Director
19.22K
+4.40%
Mr. Terry D. Ross
Mr. Terry D. Ross
Group President - Prevention and Recovery
Group President - Prevention and Recovery
18.10K
-95.45%

常见问题

Enovis Corp的前五大股东是谁?

Enovis Corp 的前五大股东如下:Mr. Daniel Alexis Pryor

有多少机构持有Enovis Corp(ENOV)的股份?

截至2026Q1,共有652家机构持有Enovis Corp的股份,合计持有的股份价值约为68.97M,占公司总股份的119.81%。与2025Q4相比,机构持股有所增加,增幅为-6763998.00。

哪个业务部门对Enovis Corp的收入贡献最大?

在2026Q1,Medical Technology-Prevention & Rehabilitation业务部门对Enovis Corp的收入贡献最大,创收1.14B,占总收入的50.58%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有